Authors:
HOSTETLER ED
JONSON SD
WELCH MJ
KATZENELLENBOGEN JA
Citation: Ed. Hostetler et al., 2-[F-18]FLUOROESTRADIOL - A RECEPTOR-BASED RADIO-PHARMACEUTICAL WITH HIGH BINDING FOR SHBG, The Journal of nuclear medicine, 39(5), 1998, pp. 127-127
Citation: Sd. Jonson et Mj. Welch, BIOLOGICAL EVALUATION AND BABOON PET IMAGING STUDIES OF THE POTENTIALADRENAL IMAGING AGENT CHOLESTERYL-P-[F-18]FLUOROBENZOATE, The Journal of nuclear medicine, 39(5), 1998, pp. 133-133
Authors:
SCRIBNER AW
JONSON SD
WELCH MJ
KATZENELLENBOGEN JA
Citation: Aw. Scribner et al., SYNTHESIS, ESTROGEN-RECEPTOR BINDING, AND TISSUE DISTRIBUTION OF [F-18] FLUORODOISYNOLIC ACIDS, Nuclear medicine and biology, 24(3), 1997, pp. 209-224
Authors:
BONASERA TA
JONSON SD
PAJEAU TS
KATZENELLENBOGEN JA
WELCH MJ
Citation: Ta. Bonasera et al., RETARDATION OF 17-OXIDATION OF 160-ALPHA-[F-18]FLUOROESTRADIOL-17-BETA BY SUBSTITUTION OF DEUTERIUM FOR HYDROGEN IN THE 17-ALPHA POSITION(6), Nuclear medicine and biology, 24(3), 1997, pp. 239-249
Citation: Rc. Gatrone et Sd. Jonson, THE INFLUENCE OF RADICAL STABILITY OF ORGANOMAGNESIUM HALIDE REAGENTSON THE DIRECTION OF ADDITION TO AN ALPHA,BETA-UNSATURATED PHOSPHORYL GROUP, Synthetic communications, 23(19), 1993, pp. 2743-2751